Genetics for understanding and predicting clinical progression in multiple sclerosis

Revue Neurologique

Volumn 167, Issue 11, 2011, Pages 791-801

  Depaz, R ^a   Granger, B ^b,c   Cournu Rebeix, I ^a,b   Bouafia, A ^a   Fontaine, B ^a,b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Epidemiology; Genetics; Multiple sclerosis

Indexed keywords

APOENZYME; BETA INTERFERON; CHEMOKINE RECEPTOR CCR5; GLATIRAMER; HLA DR ANTIGEN; HLA DR15 ANTIGEN; RANTES; VITAMIN D;

AUTOIMMUNITY; BLOOD BRAIN BARRIER; DISEASE COURSE; GENETIC ASSOCIATION; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL LESION; NERVE REGENERATION; NEUROPATHOLOGY; PHENOTYPE; REVIEW;

AUTOIMMUNITY; COMPREHENSION; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENETIC TECHNIQUES; HUMANS; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; PHENOTYPE; PROGNOSIS;

EID: 81155134161     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2011.02.043     Document Type: Review

References (89)

1. L. Almeras, B. Meresse, J. Seze, D. De Lefranc, S. Dubucquoi, and I. Fajardy Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression Eur Cytokine Netw 13 2002 200 206 (Pubitemid 34747920)
2. R. Amela-Peris, Y. Aladro, M.A. Conde-Sendin, M.J. Alemany-Rodriguez, C. Munoz-Fernandez, and M.P. Reyes-Yanez Familial multiple sclerosis in Canary Islands Rev Neurol 39 2004 911 914 (Pubitemid 39643530)
3. L.F. Barcellos, J.R. Oksenberg, A.J. Green, P. Bucher, J.B. Rimmler, and S. Schmidt Genetic basis for clinical expression in multiple sclerosis Brain 125 2002 150 158 (Pubitemid 34084044)
4. L.F. Barcellos, S. Sawcer, P.P. Ramsay, S.E. Baranzini, G. Thomson, and F. Briggs Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis Hum Mol Genet 15 2006 2813 2824 (Pubitemid 44400408)
5. R.A. Bermel, and R. Bakshi The measurement and clinical relevance of brain atrophy in multiple sclerosis Lancet Neurol 5 2006 158 170 (Pubitemid 43107851)
6. D. Brassat, C. Azais-Vuillemin, J. Yaouanq, G. Semana, J. Reboul, and I. Cournu Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group Neurology 52 1999 1632 1636 (Pubitemid 29220639)
7. N. Braun, U. Michel, B.P. Ernst, R. Metzner, A. Bitsch, and F. Weber Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production Neurosci Lett 215 1996 75 78 (Pubitemid 26313221)
8. D.E. Bulman, A.D. Sadovnick, and G.C. Ebers Age of onset in siblings concordant for multiple sclerosis Brain 114 Pt 2 1991 937 950
9. R.M. Burwick, P.P. Ramsay, J.L. Haines, S.L. Hauser, J.R. Oksenberg, and M.A. Pericak-Vance APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers Neurology 66 2006 1373 1383 (Pubitemid 43739647)
10. R.J. Butterfield, E.P. Blankenhorn, R.J. Roper, J.F. Zachary, R.W. Doerge, and C. Teuscher Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis Am J Pathol 157 2000 637 645 (Pubitemid 30626922)
11. S.J. Caillier, F. Briggs, B.A. Cree, S.E. Baranzini, M. Fernandez-Vina, and P.P. Ramsay Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis J Immunol 181 2008 5473 5480
12. R. Cayrol, K. Wosik, J.L. Berard, A. Dodelet-Devillers, I. Ifergan, and H. Kebir Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system Nat Immunol 9 2008 137 145
13. E.G. Celius, H.F. Harbo, T. Egeland, F. Vartdal, B. Vandvik, and A. Spurkiand Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis J Neurol Sci 178 2000 132 135
14. J. Chataway, A. Mander, N. Robertson, S. Sawcer, J. Deans, and M. Fraser Multiple sclerosis in sibling pairs: an analysis of 250 families J Neurol Neurosurg Psychiatry 71 2001 757 761 (Pubitemid 33121917)
15. L. Codarri, A. Fontana, and B. Becher Cytokine networks in multiple sclerosis: lost in translation Curr Opin Neurol 23 2010 205 211
16. C. Confavreux, and S. Vukusic Natural history of multiple sclerosis: a unifying concept Brain 129 2006 606 616 (Pubitemid 43278223)
17. I. Cournu-Rebeix, E. Genin, E. Leray, M.C. Babron, J. Cohen, and C. Gout HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis Genes Immun 9 2008 570 574
18. B.A. Cree, O. Khan, D. Bourdette, D.S. Goodin, J.A. Cohen, and R.A. Marrie Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis Neurology 63 2004 2039 2045 (Pubitemid 39636249)
19. P.L. De Jager, X. Jia, J. Wang, P.I. de Bakker, L. Ottoboni, and N.T. Aggarwal Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci Nat Genet 41 2009 776 782
20. E.G. de la Concha, R. Arroyo, J.B. Crusius, J.A. Campillo, C. Martin, and E. Varela de Seijas Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis J Neuroimmunol 80 1997 172 178 (Pubitemid 28015338)
21. M. Debouverie, C. Lebrun, S. Jeannin, S. Pittion-Vouyovitch, T. Roederer, and H. Vespignani More severe disability of North Africans vs Europeans with multiple sclerosis in France Neurology 68 2007 29 32 (Pubitemid 46058547)
22. G.C. DeLuca, S.V. Ramagopalan, B.M. Herrera, D.A. Dyment, M.R. Lincoln, and A. Montpetit An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus Proc Natl Acad Sci U S A 104 2007 20896 20901
23. T.H. Doolittle, R.H. Myers, J.R. Lehrich, G. Birnbaum, W. Sheremata, and G.M. Franklin Multiple sclerosis sibling pairs: clustered onset and familial predisposition Neurology 40 1990 1546 1552 (Pubitemid 20351347)
24. I. Dujmovic, K. Mangano, T. Pekmezovic, C. Quattrocchi, S. Mesaros, and N. Stojsavljevic The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy J Neuroimmunol 207 2009 101 106
25. D.A. Dyment, G.C. Ebers, and A.D. Sadovnick Genetics of multiple sclerosis Lancet Neurol 3 2004 104 110 (Pubitemid 38121313)
26. G.C. Ebers, W.J. Koopman, W. Hader, A.D. Sadovnick, M. Kremenchutzky, and P. Mandalfino The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis Brain 3 123 Pt 2000 641 649 (Pubitemid 30099546)
27. R. Feakes, S. Sawcer, S. Broadley, F. Coraddu, R. Roxburgh, and J. Gray Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis J Neuroimmunol 105 2000 96 101 (Pubitemid 30125434)
28. D.A. Francis, A.J. Thompson, P. Brookes, N. Davey, R.I. Lechler, and W.I. McDonald Multiple sclerosis and HLA: is the susceptibility gene really HLA-DR or -DQ? Hum Immunol 32 1991 119 124
29. R.J. Franklin, and C. Ffrench-Constant Remyelination in the CNS: from biology to therapy Nat Rev Neurosci 9 2008 839 855
30. D. Galimberti, C. Fenoglio, R. Clerici, C. Comi, M. De Riz, and M. Rottoli E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis J Neuroimmunol 165 2005 201 205 (Pubitemid 40984639)
31. O. Ghaffar, M. Reis, N. Pennell, P. O'Connor, and A. Feinstein APOE epsilon4 and the cognitive genetics of multiple sclerosis Neurology 74 2010 1611 1618
32. M.A. Gonzalez-Gay, C. Garcia-Porrua, and A.H. Hajeer Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis Semin Arthritis Rheum 31 2002 355 360 (Pubitemid 34734374)
33. A.E. Hensiek, S.J. Sawcer, R. Feakes, J. Deans, A. Mander, and E. Akesson HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis J Neurol Neurosurg Psychiatry 72 2002 184 187
34. A.E. Hensiek, S.R. Seaman, L.F. Barcellos, A. Oturai, M. Eraksoi, and E. Cocco Familial effects on the clinical course of multiple sclerosis Neurology 68 2007 376 383 (Pubitemid 46184215)
35. O.H. Kantarci, M. de Andrade, and B.G. Weinshenker Identifying disease modifying genes in multiple sclerosis J Neuroimmunol 123 2002 144 159 (Pubitemid 34195616)
36. O.H. Kantarci, Y. Morales, P.A. Ziemer, D.D. Hebrink, D.J. Mahad, and E.J. Atkinson CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis J Neuroimmunol 169 2005 137 143 (Pubitemid 41527099)
37. M. Khare, A. Mangalam, M. Rodriguez, C.S. David, and H.L.A. DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice J Neuroimmunol 169 2005 1 12 (Pubitemid 41527086)
38. G. Koutsis, M. Panas, E. Giogkaraki, C. Potagas, G. Karadima, and C. Sfagos APOE epsilon4 is associated with impaired verbal learning in patients with MS Neurology 68 2007 546 549
39. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452 (Pubitemid 14237132)
40. F.Q. Li, G.D. Sempowski, S.E. McKenna, D.T. Laskowitz, C.A. Colton, and M.P. Vitek Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis J Pharmacol Exp Ther 318 2006 956 965 (Pubitemid 44268300)
41. E. Losonczi, K. Bencsik, Z.F. Nagy, V. Honti, E. Szalczer, and C. Rajda Tumour necrosis factor alpha gene (TNF-alpha) -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis J Neuroimmunol 208 2009 115 118
42. C.F. Lucchinetti, W. Bruck, M. Rodriguez, and H. Lassmann Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis Brain Pathol 6 1996 259 274 (Pubitemid 26246382)
43. F. Lundmark, K. Duvefelt, E. Iacobaeus, I. Kockum, E. Wallstrom, and M. Khademi Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis Nat Genet 39 2007 1108 1113 (Pubitemid 47340654)
44. M. Luomala, T. Lehtimaki, H. Huhtala, M. Ukkonen, T. Koivula, and M. Hurme Promoter polymorphism of IL-10 and severity of multiple sclerosis Acta Neurol Scand 108 2003 396 400 (Pubitemid 37464118)
45. G. Mamutse, J. Woolmore, E. Pye, J. Partridge, M. Boggild, and C. Young Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis Mult Scler 14 2008 1280 1283
46. S. Man, E.E. Ubogu, and R.M. Ransohoff Inflammatory cell migration into the central nervous system: a few new twists on an old tale Brain Pathol 17 2007 243 250 (Pubitemid 46466143)
47. C.L. Mann, M.B. Davies, V.L. Stevenson, S.M. Leary, M.D. Boggild, and C. Ko Ko Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity J Neuroimmunol 129 2002 197 204 (Pubitemid 34879089)
48. T. Masterman, and J. Hillert HLA-DR15 and age at onset in multiple sclerosis Eur J Neurol 9 2002 179 180 (Pubitemid 35013936)
49. T. Masterman, A. Ligers, T. Olsson, M. Andersson, O. Olerup, and J. Hillert HLA-DR15 is associated with lower age at onset in multiple sclerosis Ann Neurol 48 2000 211 219 (Pubitemid 30617040)
50. A.A. Mazurek, and J. Shi APOE epsilon4 allele is associated with cognitive impairment in patients with multiple sclerosis Neurology 71 2008 1203 [author reply 1203]
51. D. McAlphine, and W.B. Matthews McAlpine's Multiple sclerosis 1985 Edinburgh New York Churchill Livingstone
52. H.F. McFarland, and R. Martin Multiple sclerosis: a complicated picture of autoimmunity Nat Immunol 8 2007 913 919 (Pubitemid 47300005)
53. E.M. Mowry, S. Deen, I. Malikova, J. Pelletier, P. Bacchetti, and E. Waubant The onset location of multiple sclerosis predicts the location of subsequent relapses J Neurol Neurosurg Psychiatry 80 2009 400 403
54. E.M. Mowry, L.B. Krupp, M. Milazzo, D. Chabas, J.B. Strober, and A.L. Belman status is associated with relapse rate in pediatric-onset multiple sclerosis Ann Neurol 67 2010 618 624
55. E.M. Mowry, M. Pesic, B. Grimes, S. Deen, P. Bacchetti, and E. Waubant Demyelinating events in early multiple sclerosis have inherent severity and recovery Neurology 72 2009 602 608
56. M. Mycko, W. Kowalski, M. Kwinkowski, A.C. Buenafe, B. Szymanska, and E. Tronczynska Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha J Neuroimmunol 84 1998 198 206 (Pubitemid 28248406)
57. R.T. Naismith, K. Trinkaus, and A.H. Cross Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review Mult Scler 12 2006 775 781 (Pubitemid 46111770)
58. J.R. Oksenberg, S.E. Baranzini, S. Sawcer, and S.L. Hauser The genetics of multiple sclerosis: SNPs to pathways to pathogenesis Nat Rev Genet 9 2008 516 526 (Pubitemid 351861542)
59. D.T. Okuda, R. Srinivasan, J.R. Oksenberg, D.S. Goodin, S.E. Baranzini, and A. Beheshtian Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures Brain 132 2009 250 259
60. O. Olerup, and J. Hillert HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation Tissue Antigens 38 1991 1 15
61. A.B. Oturai, L.P. Ryder, S. Fredrikson, K.M. Myhr, E.G. Celius, and H.F. Harbo Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs Mult Scler 10 2004 5 8 (Pubitemid 38100520)
62. P. Patrikios, C. Stadelmann, A. Kutzelnigg, H. Rauschka, M. Schmidbauer, and H. Laursen Remyelination is extensive in a subset of multiple sclerosis patients Brain 129 2006 3165 3172 (Pubitemid 44871433)
63. C. Pierrot-Deseilligny Clinical implications of a possible role of vitamin D in multiple sclerosis J Neurol 256 2009 1468 1479
64. E. Portaccio, B. Goretti, V. Zipoli, B. Nacmias, M.L. Stromillo, and M.L. Bartolozzi APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis Mult Scler 15 2009 1489 1494
65. K. Pulkkinen, M. Luomala, H. Kuusisto, T. Lehtimaki, M. Saarela, and T.O. Jalonen Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis Acta Neurol Scand 109 2004 342 347 (Pubitemid 38580902)
66. R.M. Ransohoff Natalizumab for multiple sclerosis N Engl J Med 356 2007 2622 2629 (Pubitemid 46961007)
67. N.P. Robertson, D. Clayton, M. Fraser, J. Deans, and D.A. Compston Clinical concordance in sibling pairs with multiple sclerosis Neurology 47 1996 347 352 (Pubitemid 26324026)
68. R.H. Roxburgh, S.R. Seaman, T. Masterman, A.E. Hensiek, S.J. Sawcer, and S. Vukusic Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity Neurology 64 2005 1144 1151
69. B. Runmarker, T. Martinsson, J. Wahlstrom, and O. Andersen HLA and prognosis in multiple sclerosis J Neurol 241 1994 385 390 (Pubitemid 24172335)
70. A.D. Sadovnick, and D.H. Jacobs MS and cognition and APOE: the ongoing conundrum about biomarkers Neurology 70 2008 164 165
71. J. Satsangi, C. Grootscholten, H. Holt, and D.P. Jewell Clinical patterns of familial inflammatory bowel disease Gut 38 1996 738 741 (Pubitemid 26167483)
72. D. Scalabrini, D. Galimberti, C. Fenoglio, C. Comi, M. De Riz, and E. Venturelli P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis Neurosci Lett 388 2005 149 152 (Pubitemid 41208210)
73. K. Schreiber, A.B. Otura, L.P. Ryder, H.O. Madsen, O.S. Jorgensen, and A. Svejgaard Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E) Mult Scler 8 2002 295 298 (Pubitemid 34784756)
74. F.L. Sciacca, C. Ferri, K. Vandenbroeck, F. Veglia, C. Gobbi, and F. Martinelli Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients Neurology 52 1999 1896 1898 (Pubitemid 29260907)
75. M.K. Sharief, and R. Hentges Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis N Engl J Med 325 1991 467 472
76. J. Shi, C.B. Zhao, T.L. Vollmer, T.M. Tyry, and S.M. Kuniyoshi APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis Neurology 70 2008 185 190
77. A.M. Silva, C. Pereira, A. Bettencourt, C. Carvalho, A.R. Couto, and M.I. Leite The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population J Neurol Sci 258 2007 69 74 (Pubitemid 46874479)
78. C. Smestad, B. Brynedal, G. Jonasdottir, A.R. Lorentzen, T. Masterman, and E. Akesson The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients Eur J Neurol 14 2007 835 840 (Pubitemid 47108189)
79. J. Smolders, E. Peelen, M. Thewissen, P. Menheere, J.W. Cohen Tervaert, and R. Hupperts The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis Autoimmun Rev 8 2009 621 626
80. T.L. Sorensen, M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, and V.A. Folcik Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients J Clin Invest 103 1999 807 815 (Pubitemid 29152626)
81. E. Sundqvist, M. Baarnhielm, L. Alfredsson, J. Hillert, T. Olsson, and I. Kockum Confirmation of association between multiple sclerosis and CYP27B1 Eur J Hum Genet 18 2010 1349 1352
82. L. Tajouri, M. Ovcaric, R. Curtain, M.P. Johnson, L.R. Griffiths, and P. Csurhes Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population J Neurogenet 19 2005 25 38 (Pubitemid 41656874)
83. M. Trojano, M. Liguori, F. De Robertis, A. Stella, G. Guanti, and C. Avolio Comparison of clinical and demographic features between affected pairs of Italian multiple sclerosis multiplex families; relation to tumour necrosis factor genomic polymorphisms J Neurol Sci 162 1999 194 200 (Pubitemid 29125253)
84. B.P. Tsao, J.M. Grossman, G. Riemekasten, N. Strong, J. Kalsi, and D.J. Wallace Familiality and co-occurrence of clinical features of systemic lupus erythematosus Arthritis Rheum 46 2002 2678 2685 (Pubitemid 36118932)
85. J.L. Tu, C.B. Zhao, T. Vollmer, S. Coons, H.J. Lin, and S. Marsh APOE 4 polymorphism results in early cognitive deficits in an EAE model Biochem Biophys Res Commun 384 2009 466 470
86. A. van der Walt, J. Stankovich, M. Bahlo, B.V. Taylor, I.A. van der Mei, and S.J. Foote Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy Neurology 73 2009 1018 1025
87. T. van Veen, J. Nielsen, J. Berkhof, F. Barkhof, W. Kamphorst, and L. Bo CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis J Neuroimmunol 190 2007 157 164 (Pubitemid 47625612)
88. B.G. Weinshenker, D. Bulman, W. Carriere, J. Baskerville, and G.C. Ebers A comparison of sporadic and familial multiple sclerosis Neurology 40 1990 1354 1358 (Pubitemid 20291639)
89. R. Zivadinov, L. Uxa, T. Zacchi, D. Nasuelli, M. Ukmar, and C. Furlan HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis J Neurol 250 2003 1099 1106 (Pubitemid 37152560)